Literature DB >> 22595830

Initial choice of antihypertensive on long-term cardiovascular outcomes in CKD.

Adam Whaley-Connell, James R Sowers.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22595830      PMCID： PMC3362307          DOI： 10.2215/CJN.04130412

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  14 in total

1.  Cardiovascular outcomes in the African American Study of Kidney Disease and Hypertension (AASK) Trial.

Authors:  Keith Norris; Jacque Bourgoigne; Jennifer Gassman; Lee Hebert; John Middleton; Robert A Phillips; Otelio Randall; Stephen Rostand; Susan Sherer; Robert D Toto; Jackson T Wright; Xuelei Wang; Tom Greene; Lawrence J Appel; Julia Lewis
Journal:  Am J Kidney Dis       Date:  2006-11       Impact factor: 8.860

2.  Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.

Authors: 
Journal:  BMJ       Date:  1998-09-12

3.  The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.

Authors:  H H Parving; H Lehnert; J Bröchner-Mortensen; R Gomis; S Andersen; P Arner
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

4.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Authors:  B M Brenner; M E Cooper; D de Zeeuw; W F Keane; W E Mitch; H H Parving; G Remuzzi; S M Snapinn; Z Zhang; S Shahinfar
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

5.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

6.  Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors:  Mahboob Rahman; Sara Pressel; Barry R Davis; Chuke Nwachuku; Jackson T Wright; Paul K Whelton; Joshua Barzilay; Vecihi Batuman; John H Eckfeldt; Michael Farber; Mario Henriquez; Nelson Kopyt; Gail T Louis; Mohammad Saklayen; Carol Stanford; Candace Walworth; Harry Ward; Thomas Wiegmann
Journal:  Arch Intern Med       Date:  2005-04-25

7.  Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR.

Authors:  Mahboob Rahman; Charles E Ford; Jeffrey A Cutler; Barry R Davis; Linda B Piller; Paul K Whelton; Jackson T Wright; Joshua I Barzilay; Clinton D Brown; Pedro J Colon; Lawrence J Fine; Richard H Grimm; Alok K Gupta; Charles Baimbridge; L Julian Haywood; Mario A Henriquez; Ekambaram Ilamaythi; Suzanne Oparil; Richard Preston
Journal:  Clin J Am Soc Nephrol       Date:  2012-04-05       Impact factor: 8.237

8.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

9.  Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.

Authors:  Mahboob Rahman; Sara Pressel; Barry R Davis; Chuke Nwachuku; Jackson T Wright; Paul K Whelton; Joshua Barzilay; Vecihi Batuman; John H Eckfeldt; Michael A Farber; Stanley Franklin; Mario Henriquez; Nelson Kopyt; Gail T Louis; Mohammad Saklayen; Carole Stanford; Candace Walworth; Harry Ward; Thomas Wiegmann
Journal:  Ann Intern Med       Date:  2006-02-07       Impact factor: 25.391

10.  Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus.

Authors:  Holly J Kramer; Quan Dong Nguyen; Gary Curhan; Chi-Yuan Hsu
Journal:  JAMA       Date:  2003-06-25       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.